ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
60.65
+0.49 (0.81%)
At close: May 20, 2025, 4:00 PM
60.64
-0.01 (-0.02%)
After-hours: May 20, 2025, 4:43 PM EDT
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for ANI Pharmaceuticals stock ranges from a low of $65 to a high of $94. The average analyst price target of $80.13 forecasts a 32.12% increase in the stock price over the next year.
Price Target: $80.13 (+32.12%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ANI Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $86 | Strong Buy | Reiterates | $86 | +41.80% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $62 → $65 | Hold | Maintains | $62 → $65 | +7.17% | Apr 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $86 | Strong Buy | Reiterates | $86 | +41.80% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $94 | Strong Buy | Reiterates | $94 | +54.99% | Mar 17, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +31.90% | Mar 14, 2025 |
Financial Forecast
Revenue This Year
797.89M
from 614.38M
Increased by 29.87%
Revenue Next Year
857.99M
from 797.89M
Increased by 7.53%
EPS This Year
6.59
from -1.04
EPS Next Year
7.22
from 6.59
Increased by 9.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 836.4M | 910.9M | 995.5M | ||
| Avg | 797.9M | 858.0M | 912.2M | ||
| Low | 751.5M | 802.8M | 830.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.1% | 14.2% | 16.0% | ||
| Avg | 29.9% | 7.5% | 6.3% | ||
| Low | 22.3% | 0.6% | -3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.94 | 8.48 | 10.43 | ||
| Avg | 6.59 | 7.22 | 8.32 | ||
| Low | 6.09 | 6.04 | 6.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 28.8% | 44.3% | ||
| Avg | - | 9.7% | 15.2% | ||
| Low | - | -8.3% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.